Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             169 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accumulation of ubiquitin-conjugated cytokeratin fragments in tumor cells Iwaya, Keiichi
 2005
 40-41 4 p. 309-318
10 p.
 artikel
2 Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors Mescher, Matthew F.
 2007
 40-41 4 p. 299-308
10 p.
 artikel
3 Adaptation and learning of molecular networks as a description of cancer development at the systems-level: Potential use in anti-cancer therapies Gyurkó, Dávid M.
 2013
 40-41 4 p. 262-269
8 p.
 artikel
4 All y’all need to know ‘bout retroelements in cancer Belancio, Victoria P.
 2010
 40-41 4 p. 200-210
11 p.
 artikel
5 Altered hyaluronan biosynthesis in cancer progression Itano, Naoki
 2008
 40-41 4 p. 268-274
7 p.
 artikel
6 Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime? Fuchs, Bryan C.
 2005
 40-41 4 p. 254-266
13 p.
 artikel
7 A mobile threat to genome stability: The impact of non-LTR retrotransposons upon the human genome Konkel, Miriam K.
 2010
 40-41 4 p. 211-221
11 p.
 artikel
8 Applications of RNA interference for studies in DNA damage processing, genome stability, mutagenesis, and cancer Bedford, Joel S
 2003
 40-41 4 p. 301-308
8 p.
 artikel
9 Are particular Epstein–Barr virus strains linked to disease? Jenkins*, Peter J.
 1996
 40-41 4 p. 209-215
7 p.
 artikel
10 Arginine deprivation and metabolomics: Important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells Wheatley, Denys N.
 2005
 40-41 4 p. 247-253
7 p.
 artikel
11 Association between cancer and “acid mucopolysaccharides”: An old concept comes of age, finally Stern, Robert
 2008
 40-41 4 p. 238-243
6 p.
 artikel
12 BK virus and human cancer: Innocent until proven guilty Abend, Johanna R.
 2009
 40-41 4 p. 252-260
9 p.
 artikel
13 Cancer dormancy: from observation to investigation and onto clinical intervention Yefenof, Eitan
 2001
 40-41 4 p. 269-270
2 p.
 artikel
14 Cancer networks and beyond: Interpreting mutations using the human interactome and protein structure Gulati, Sakshi
 2013
 40-41 4 p. 219-226
8 p.
 artikel
15 Cancer-related networks: A help to understand, predict and change malignant transformation Csermely, Peter
 2013
 40-41 4 p. 209-212
4 p.
 artikel
16 Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks Wang, Edwin
 2013
 40-41 4 p. 279-285
7 p.
 artikel
17 Cancer systems biology in the genome sequencing era: Part 2, evolutionary dynamics of tumor clonal networks and drug resistance Wang, Edwin
 2013
 40-41 4 p. 286-292
7 p.
 artikel
18 Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens Cheng, Jingwei
 2009
 40-41 4 p. 218-228
11 p.
 artikel
19 Complex regulation of autophagy in cancer – Integrated approaches to discover the networks that hold a double-edged sword Kubisch, János
 2013
 40-41 4 p. 252-261
10 p.
 artikel
20 Conditional transgenic models define how MYC initiates and maintains tumorigenesis Arvanitis, Constadina
 2006
 40-41 4 p. 313-317
5 p.
 artikel
21 Control and activity of type-1 serine/threonine protein phosphatase during the cell cycle Ludlow, John W.
 1995
 40-41 4 p. 195-202
8 p.
 artikel
22 Cooperation and competition in the dynamics of tissue architecture during homeostasis and tumorigenesis Csikász-Nagy, Attila
 2013
 40-41 4 p. 293-298
6 p.
 artikel
23 Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression Ostrand-Rosenberg, Suzanne
 2012
 40-41 4 p. 275-281
7 p.
 artikel
24 Cyclin E as a prognostic and predictive marker in breast cancer Hunt, Kelly K.
 2005
 40-41 4 p. 319-326
8 p.
 artikel
25 DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death Bialik, Shani
 2004
 40-41 4 p. 283-294
12 p.
 artikel
26 Dendritic cells, antigen distribution and the initiation of primary immune responses to self and non-self antigens Knight, Stella C
 2002
 40-41 4 p. 301-308
8 p.
 artikel
27 Dietary fat intake and cancer risk: a controversial and instructive story Willett, Walter C.
 1998
 40-41 4 p. 245-253
9 p.
 artikel
28 Differentiation and gene expression profile of tumor-associated macrophages Schmieder, Astrid
 2012
 40-41 4 p. 289-297
9 p.
 artikel
29 Do autochthonous tumors interfere with effector T cell responses? Blankenstein, Thomas
 2007
 40-41 4 p. 267-274
8 p.
 artikel
30 Dormancy in a model of murine B cell lymphoma Uhr, Jonathan W.
 2001
 40-41 4 p. 277-283
7 p.
 artikel
31 Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients Riethmüller, Gert
 2001
 40-41 4 p. 307-311
5 p.
 artikel
32 Early phenotypic changes of in vitro transformed cells during in vivo progression: possible role of the host innate immunity Deichman, Galina I
 2002
 40-41 4 p. 317-326
10 p.
 artikel
33 EBV infection of T cells: potential role in malignant transformation Kelleher, Colm A.
 1996
 40-41 4 p. 197-207
11 p.
 artikel
34 Editorial Board 2013
 40-41 4 p. IFC-
1 p.
 artikel
35 Editorial Board 2008
 40-41 4 p. CO2-
1 p.
 artikel
36 Editorial Board 2007
 40-41 4 p. CO2-
1 p.
 artikel
37 Editorial Board 2009
 40-41 4 p. CO2-
1 p.
 artikel
38 Editorial Board 2010
 40-41 4 p. CO2-
1 p.
 artikel
39 Editorial Board 2012
 40-41 4 p. CO2-
1 p.
 artikel
40 Editorial Board & Publication Information 2011
 40-41 4 p. CO2-
1 p.
 artikel
41 Emerging importance of ALK in neuroblastoma Azarova, Anna M.
 2011
 40-41 4 p. 267-275
9 p.
 artikel
42 Epstein–Barr virus and gastric carcinoma Osato, Toyoro
 1996
 40-41 4 p. 175-182
8 p.
 artikel
43 Epstein–Barr virus and human T-cell lymphomas Meijer, C.J.L.M.
 1996
 40-41 4 p. 191-196
6 p.
 artikel
44 Epstein–Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma Ambinder, Richard F.
 1996
 40-41 4 p. 217-226
10 p.
 artikel
45 Epstein–Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma Niedobitek, Gerald
 1996
 40-41 4 p. 165-174
10 p.
 artikel
46 Epstein–Barr virus in Hodgkin's disease Herbst, Hermann
 1996
 40-41 4 p. 183-189
7 p.
 artikel
47 Exposing oncogenic dependencies for cancer drug target discovery and validation using RNAi Deveraux, Quinn L
 2003
 40-41 4 p. 293-300
8 p.
 artikel
48 Flicking the switches: phosphorylation of serine/threonine protein phosphatases Brautigan, David L.
 1995
 40-41 4 p. 211-217
7 p.
 artikel
49 Fusion genes in solid tumors Aman, Pierre
 1999
 40-41 4 p. 303-318
16 p.
 artikel
50 Genes and environment in the etiology of colorectal cancer Gertig, Dorota M.
 1998
 40-41 4 p. 285-298
14 p.
 artikel
51 Genetically engineered murine models – Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma Chesler, Louis
 2011
 40-41 4 p. 245-255
11 p.
 artikel
52 Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis Breivik, Jarle
 1999
 40-41 4 p. 245-254
10 p.
 artikel
53 Genomic rearrangements in inherited disease and cancer Chen, Jian-Min
 2010
 40-41 4 p. 222-233
12 p.
 artikel
54 Growing evidence that several human cancers may originatein utero Ekbom, Anders
 1998
 40-41 4 p. 237-244
8 p.
 artikel
55 Hereditary breast cancer: a review Arver, Brita
 2000
 40-41 4 p. 271-288
18 p.
 artikel
56 Hereditary cutaneous melanoma Platz, Anton
 2000
 40-41 4 p. 319-326
8 p.
 artikel
57 Hereditary intestinal cancer Aaltonen, Lauri A
 2000
 40-41 4 p. 289-298
10 p.
 artikel
58 How to escape the cancer attractor: Rationale and limitations of multi-target drugs Huang, Sui
 2013
 40-41 4 p. 270-278
9 p.
 artikel
59 Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells Toole, Bryan P.
 2008
 40-41 4 p. 244-250
7 p.
 artikel
60 Hyaluronan in Cancer Biology Stern, Robert
 2008
 40-41 4 p. 237-
1 p.
 artikel
61 Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan Tammi, Raija H.
 2008
 40-41 4 p. 288-295
8 p.
 artikel
62 Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression Bourguignon, Lilly Y.W.
 2008
 40-41 4 p. 251-259
9 p.
 artikel
63 Hyalurondiase: Both a tumor promoter and suppressor Lokeshwar, Vinata B.
 2008
 40-41 4 p. 281-287
7 p.
 artikel
64 Hyaluronidase 2 and its intriguing role as a cell-entry receptor for oncogenic sheep retroviruses Miller, A. Dusty
 2008
 40-41 4 p. 296-301
6 p.
 artikel
65 Hyaluronidases in cancer biology Stern, Robert
 2008
 40-41 4 p. 275-280
6 p.
 artikel
66 Immune suppression in renal cell carcinoma Frankenberger, Bernhard
 2007
 40-41 4 p. 330-343
14 p.
 artikel
67 Immunity to polyomavirus infection: The polyomavirus–mouse model Swanson II, Phillip A.
 2009
 40-41 4 p. 244-251
8 p.
 artikel
68 Immunology and immunotherapy of neuroblastoma Seeger, Robert C.
 2011
 40-41 4 p. 229-237
9 p.
 artikel
69 Immunosuppression in the tumor microenvironment: Where are we standing? Umansky, Viktor
 2012
 40-41 4 p. 273-274
2 p.
 artikel
70 Implication of direct host–tumor intercellular interactions in non-immune host resistance to neoplastic growth Krutovskikh, Vladimir
 2002
 40-41 4 p. 267-276
10 p.
 artikel
71 Inducible nitric oxide synthase (iNOS) in tumor biology: The two sides of the same coin Lechner, Matthias
 2005
 40-41 4 p. 277-289
13 p.
 artikel
72 Inherited epithelial tumors of the kidney: old and new diseases Zbar, Berton
 2000
 40-41 4 p. 313-318
6 p.
 artikel
73 Inhibitory costimulation and anti-tumor immunity Martin-Orozco, Natalia
 2007
 40-41 4 p. 288-298
11 p.
 artikel
74 In search of drug treatment for genetic defects in the DNA damage response: the example of ataxia-telangiectasia Shiloh, Yosef
 2004
 40-41 4 p. 295-305
11 p.
 artikel
75 Integrated network analyses for functional genomic studies in cancer Wilson, Jennifer L.
 2013
 40-41 4 p. 213-218
6 p.
 artikel
76 Interleukin-1—a major pleiotropic cytokine in tumor–host interactions Apte, Ron N
 2002
 40-41 4 p. 277-290
14 p.
 artikel
77 Introduction Trichopoulos, Dimitrios
 1998
 40-41 4 p. 215-217
3 p.
 artikel
78 Introduction Imreh, Stephan
 1999
 40-41 4 p. 241-244
4 p.
 artikel
79 Introduction: Epstein–Barr virus and non-B cell tumours Young, Lawrence S.
 1996
 40-41 4 p. 163-164
2 p.
 artikel
80 Introduction: innate host antitumor immunity and tumor progression Deichman, Galina I
 2002
 40-41 4 p. 259-260
2 p.
 artikel
81 Introduction: Protein serine/threonine phosphatases and growth control Walter, Gernot
 1995
 40-41 4 p. 193-194
2 p.
 artikel
82 Introduction: RNA interference in cancer biology and treatment Borkhardt, Arndt
 2003
 40-41 4 p. 249-251
3 p.
 artikel
83 Introduction: Signal transduction therapy—10 years later Levitzki, A
 2004
 40-41 4 p. 219-221
3 p.
 artikel
84 Involvement of CD44, a molecule with a thousand faces, in cancer dissemination Naor, David
 2008
 40-41 4 p. 260-267
8 p.
 artikel
85 IsHelicobacter pylorireally the cause of gastric cancer? Nyrén, Olof
 1998
 40-41 4 p. 275-283
9 p.
 artikel
86 JC Virus: An oncogenic virus in animals and humans? Maginnis, Melissa S.
 2009
 40-41 4 p. 261-269
9 p.
 artikel
87 KI, WU and Merkel cell polyomaviruses: A new era for human polyomavirus research Dalianis, Tina
 2009
 40-41 4 p. 270-275
6 p.
 artikel
88 Making the tumor-specific effectors ineffective Levitsky, Victor
 2007
 40-41 4 p. 265-266
2 p.
 artikel
89 Manipulation of the tumor suppressor p53 for potentiating cancer therapy Haupt, Susan
 2004
 40-41 4 p. 244-252
9 p.
 artikel
90 Mechanism of transcriptional activation by the Myc oncoproteins Cowling, Victoria H.
 2006
 40-41 4 p. 242-252
11 p.
 artikel
91 Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells Seo, Naohiro
 2002
 40-41 4 p. 291-300
10 p.
 artikel
92 Melanoma-induced immunosuppression and its neutralization Umansky, Viktor
 2012
 40-41 4 p. 319-326
8 p.
 artikel
93 Metabolic mechanisms of cancer-induced inhibition of immune responses Viola, Antonella
 2007
 40-41 4 p. 309-316
8 p.
 artikel
94 Metabolic network modeling approaches for investigating the “hungry cancer” Sharma, Ashwini Kumar
 2013
 40-41 4 p. 227-234
8 p.
 artikel
95 MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation Stallings, Raymond L.
 2011
 40-41 4 p. 283-290
8 p.
 artikel
96 MicroRNAs and cancer McManus, Michael T
 2003
 40-41 4 p. 253-258
6 p.
 artikel
97 Mobilizing the low-avidity T cell repertoire to kill tumors McMahan, Rachel H.
 2007
 40-41 4 p. 317-329
13 p.
 artikel
98 Molecular evolution of chronic myeloid leukaemia Shteper, Pesach J
 2001
 40-41 4 p. 313-322
10 p.
 artikel
99 Molecular genetics of breast cancer progression Ingvarsson, Sigurdur
 1999
 40-41 4 p. 277-288
12 p.
 artikel
100 Multiple endocrine neoplasia type 1 Ki Wong, Fung
 2000
 40-41 4 p. 299-312
14 p.
 artikel
101 Multi-step evolution of lung cancer Braithwaite, Kerynne L.
 1999
 40-41 4 p. 255-265
11 p.
 artikel
102 Murine polyomavirus tumour specific transplantation antigens and viral persistence in relation to the immune response, and tumour development Ramqvist, Torbjörn
 2009
 40-41 4 p. 236-243
8 p.
 artikel
103 Myc in model organisms: A view from the flyroom de la Cova, Claire
 2006
 40-41 4 p. 303-312
10 p.
 artikel
104 Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage Mohlin, Sofie A.
 2011
 40-41 4 p. 276-282
7 p.
 artikel
105 Neuroblastoma genetics and phenotype: A tale of heterogeneity Speleman, Frank
 2011
 40-41 4 p. 238-244
7 p.
 artikel
106 Neuroblastoma research progress – A 2011 perspective Henriksson, Marie Arsenian
 2011
 40-41 4 p. 215-216
2 p.
 artikel
107 New insights into chronic inflammation-induced immunosuppression Kanterman, Julia
 2012
 40-41 4 p. 307-318
12 p.
 artikel
108 Oncogene amplification in solid tumors Schwab, Manfred
 1999
 40-41 4 p. 319-325
7 p.
 artikel
109 Oncogenic growth factor receptors: implications for signal transduction therapy Mosesson, Yaron
 2004
 40-41 4 p. 262-270
9 p.
 artikel
110 Plasma free amino acid profile in cancer patients Lai, Hong-Shiee
 2005
 40-41 4 p. 267-276
10 p.
 artikel
111 Polyoma virus and simian virus 40 as cancer models: History and perspectives Atkin, Sarah J.L.
 2009
 40-41 4 p. 211-217
7 p.
 artikel
112 Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer Romanish, M.T.
 2010
 40-41 4 p. 246-253
8 p.
 artikel
113 Potentials for RNAi in sarcoma research and therapy: Ewing’s sarcoma as a model Kovar, Heinrich
 2003
 40-41 4 p. 275-281
7 p.
 artikel
114 Prenyl-binding domains: potential targets for Ras inhibitors and anti-cancer drugs Kloog, Yoel
 2004
 40-41 4 p. 253-261
9 p.
 artikel
115 Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research Øra, Ingrid
 2011
 40-41 4 p. 217-228
12 p.
 artikel
116 Progression as exemplified by human astrocytic tumors Collins, V.P.
 1999
 40-41 4 p. 267-276
10 p.
 artikel
117 Protein phosphatase regulation by endogenous inhibitors Shenolikar, Shirish
 1995
 40-41 4 p. 219-227
9 p.
 artikel
118 Pyruvate kinase type M2 and its role in tumor growth and spreading Mazurek, Sybille
 2005
 40-41 4 p. 300-308
9 p.
 artikel
119 Ras interference as cancer therapy Duursma, Anja M
 2003
 40-41 4 p. 267-273
7 p.
 artikel
120 Recent advances on the role of tumor exosomes in immunosuppression and disease progression Filipazzi, Paola
 2012
 40-41 4 p. 342-349
8 p.
 artikel
121 Regulation by tumour antigens defines a role for PP2A in signal transduction Mumby, Marc
 1995
 40-41 4 p. 229-237
9 p.
 artikel
122 Regulation of gene expression by serine/threonine protein phosphatases Schönthal, Axel H.
 1995
 40-41 4 p. 239-248
10 p.
 artikel
123 Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells Nagaraj, Srinivas
 2012
 40-41 4 p. 282-288
7 p.
 artikel
124 Repetitive elements and genome instability Ivics, Zoltán
 2010
 40-41 4 p. 197-199
3 p.
 artikel
125 Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer DiCiommo, David
 2000
 40-41 4 p. 255-269
15 p.
 artikel
126 RNA interference: gene silencing in the fast lane Kittler, Ralf
 2003
 40-41 4 p. 259-265
7 p.
 artikel
127 RNA molecules as anti-cancer agents Friedrich, Inbar
 2004
 40-41 4 p. 223-230
8 p.
 artikel
128 Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function Hann, Stephen R.
 2006
 40-41 4 p. 288-302
15 p.
 artikel
129 Role of protein phosphatase 2A in Drosophila development Mayer-Jaekel, Regina E.
 1995
 40-41 4 p. 249-256
8 p.
 artikel
130 Solitary cancer cells as a possible source of tumour dormancy? Naumov, George N.
 2001
 40-41 4 p. 271-276
6 p.
 artikel
131 Stress-activated protein kinases—tumor suppressors or tumor initiators? Engelberg, David
 2004
 40-41 4 p. 271-282
12 p.
 artikel
132 SVA retrotransposons: Evolution and genetic instability Hancks, Dustin C.
 2010
 40-41 4 p. 234-245
12 p.
 artikel
133 T antigen transgenic mouse models Sáenz Robles, Maria Teresa
 2009
 40-41 4 p. 229-235
7 p.
 artikel
134 Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate” 2004
 40-41 4 p. 306-
1 p.
 artikel
135 Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate Coutré, Steven
 2004
 40-41 4 p. 307-315
9 p.
 artikel
136 Targeting oncogenic fusion genes in leukemias and lymphomas by RNA interference Damm-Welk, Christine
 2003
 40-41 4 p. 283-292
10 p.
 artikel
137 T-cell immunity in the induction and maintenance of a tumour dormant state Schirrmacher, V
 2001
 40-41 4 p. 285-295
11 p.
 artikel
138 The biological role of the Fas/FasL system during tumor formation and progression Reichmann, Ernst
 2002
 40-41 4 p. 309-315
7 p.
 artikel
139 The biology of inherited cancer Lindblom, Annika
 2000
 40-41 4 p. 251-254
4 p.
 artikel
140 The c-Myc target gene network Dang, Chi V.
 2006
 40-41 4 p. 253-264
12 p.
 artikel
141 The genomic risk of somatic gene therapy Kustikova, Olga
 2010
 40-41 4 p. 269-278
10 p.
 artikel
142 The global burden of cancer Parkin, D.M.
 1998
 40-41 4 p. 219-235
17 p.
 artikel
143 The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer Nachmias, Boaz
 2004
 40-41 4 p. 231-243
13 p.
 artikel
144 The MAX-interacting transcription factor network Hurlin, Peter J.
 2006
 40-41 4 p. 265-274
10 p.
 artikel
145 The mitotic machinery as a source of genetic instability in cancer Pihan, German A.
 1999
 40-41 4 p. 289-302
14 p.
 artikel
146 The molecular basis of targeting protein kinases in cancer therapeutics Tsai, Chung-Jung
 2013
 40-41 4 p. 235-242
8 p.
 artikel
147 The MYCN oncogene and differentiation in neuroblastoma Westermark, Ulrica K.
 2011
 40-41 4 p. 256-266
11 p.
 artikel
148 The Myc oncoprotein as a therapeutic target for human cancer Vita, Marina
 2006
 40-41 4 p. 318-330
13 p.
 artikel
149 The Oscar-worthy role of Myc in apoptosis Meyer, Natalie
 2006
 40-41 4 p. 275-287
13 p.
 artikel
150 The role of classical and non-classical HLA class I antigens in human tumors Bukur, Juergen
 2012
 40-41 4 p. 350-358
9 p.
 artikel
151 The role of human papillomaviruses in anogenital cancers Melbye, Mads
 1998
 40-41 4 p. 307-313
7 p.
 artikel
152 The role of protein phosphatase type-2A in the Xenopus cell cycle: initiation of the G2/M transition Lee, Tina H.
 1995
 40-41 4 p. 203-209
7 p.
 artikel
153 The structural network of inflammation and cancer: Merits and challenges Guven Maiorov, Emine
 2013
 40-41 4 p. 243-251
9 p.
 artikel
154 The study of metabolic pathways in tumors based on the transcriptome Bono, Hidemasa
 2005
 40-41 4 p. 290-299
10 p.
 artikel
155 Towards an understanding of breast cancer etiology Adami, Hans-Olov
 1998
 40-41 4 p. 255-262
8 p.
 artikel
156 Towards global control of liver cancer? Stuver, Sherri O.
 1998
 40-41 4 p. 299-306
8 p.
 artikel
157 Transposon-based screens for cancer gene discovery in mouse models Dupuy, Adam J.
 2010
 40-41 4 p. 261-268
8 p.
 artikel
158 Tumor associated regulatory dendritic cells Ma, Yang
 2012
 40-41 4 p. 298-306
9 p.
 artikel
159 Tumor immunoediting and immunosculpting pathways to cancer progression Reiman, Jennifer M.
 2007
 40-41 4 p. 275-287
13 p.
 artikel
160 Tumor metabolism as modulator of immune response and tumor progression Gottfried, Eva
 2012
 40-41 4 p. 335-341
7 p.
 artikel
161 “Tumor metabolome”: A post-modern genomic view on the role of low molecular weight substances in cancerous cell growth. An introduction Falus, Andras
 2005
 40-41 4 p. 245-246
2 p.
 artikel
162 Tumor progression: a brief historical perspective Nowell, Peter C
 2002
 40-41 4 p. 261-266
6 p.
 artikel
163 Tumor specific activation of PKR as a non-toxic modality of cancer treatment Shir, Alexei
 2003
 40-41 4 p. 309-314
6 p.
 artikel
164 Tumour dormancy: findings and hypotheses from clinical research on breast cancer Demicheli, Romano
 2001
 40-41 4 p. 297-305
9 p.
 artikel
165 V(D)J recombination: Born to be wild Ramsden, Dale A.
 2010
 40-41 4 p. 254-260
7 p.
 artikel
166 Welcome to the Polyomaviridae Dalianis, Tina
 2009
 40-41 4 p. 209-210
2 p.
 artikel
167 What are regulatory T cells (Treg) regulating in cancer and why? Whiteside, Theresa L.
 2012
 40-41 4 p. 327-334
8 p.
 artikel
168 What causes prostate cancer? A brief summary of the epidemiology Chan, June M.
 1998
 40-41 4 p. 263-273
11 p.
 artikel
169 25 years of the c-Myc oncogene Cole, Michael D.
 2006
 40-41 4 p. 241-
1 p.
 artikel
                             169 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland